Shah, M. K., Shah, M. A., & Shah, S. D. (2019). Risk of hypertension with bevacizumab, an antibody against vascular endothelial growth factor A: a systematic review and meta-analysis. International Journal of Basic & Clinical Pharmacology, 8(10), 2354–2360. https://doi.org/10.18203/2319-2003.ijbcp20194287